These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21455726)

  • 1. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
    Ferreira DM; Castro RE; Machado MV; Evangelista T; Silvestre A; Costa A; Coutinho J; Carepa F; Cortez-Pinto H; Rodrigues CM
    Diabetologia; 2011 Jul; 54(7):1788-98. PubMed ID: 21455726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic differences in intra-abdominal adipose tissue in extremely obese adolescents with different stages of NAFLD.
    Sheldon RD; Kanosky KM; Wells KD; Miles L; Perfield JW; Xanthakos S; Inge TH; Rector RS
    Physiol Genomics; 2016 Dec; 48(12):897-911. PubMed ID: 27764764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
    Svegliati-Baroni G; Candelaresi C; Saccomanno S; Ferretti G; Bachetti T; Marzioni M; De Minicis S; Nobili L; Salzano R; Omenetti A; Pacetti D; Sigmund S; Benedetti A; Casini A
    Am J Pathol; 2006 Sep; 169(3):846-60. PubMed ID: 16936261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
    Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
    Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH.
    Yoon MY; Sung JM; Song CS; Lee WY; Rhee EJ; Shin JH; Yoo CH; Chae SW; Kim JY; Jin W; Cho YK
    Clin Mol Hepatol; 2012 Sep; 18(3):279-86. PubMed ID: 23091808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
    J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle.
    Kitajima Y; Hyogo H; Sumida Y; Eguchi Y; Ono N; Kuwashiro T; Tanaka K; Takahashi H; Mizuta T; Ozaki I; Eguchi T; Kimura Y; Fujimoto K; Anzai K;
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1507-14. PubMed ID: 23577962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
    D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
    Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.
    Valenti L; Mendoza RM; Rametta R; Maggioni M; Kitajewski C; Shawber CJ; Pajvani UB
    Diabetes; 2013 Dec; 62(12):4052-62. PubMed ID: 23990360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
    Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
    J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.
    Jones H; Sprung VS; Pugh CJ; Daousi C; Irwin A; Aziz N; Adams VL; Thomas EL; Bell JD; Kemp GJ; Cuthbertson DJ
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3709-16. PubMed ID: 22837189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.
    Gaddipati R; Sasikala M; Padaki N; Mukherjee RM; Sekaran A; Jayaraj-Mansard M; Rabella P; Rao-Guduru V; Reddy-Duvvuru N
    Ann Hepatol; 2010; 9(3):266-70. PubMed ID: 20720266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance.
    Machado MV; Ferreira DM; Castro RE; Silvestre AR; Evangelista T; Coutinho J; Carepa F; Costa A; Rodrigues CM; Cortez-Pinto H
    PLoS One; 2012; 7(2):e31738. PubMed ID: 22359625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH.
    Hedjazifar S; Khatib Shahidi R; Hammarstedt A; Bonnet L; Church C; Boucher J; Blüher M; Smith U
    Diabetes; 2020 Mar; 69(3):331-341. PubMed ID: 31882566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.
    Apostolopoulou M; Gordillo R; Koliaki C; Gancheva S; Jelenik T; De Filippo E; Herder C; Markgraf D; Jankowiak F; Esposito I; Schlensak M; Scherer PE; Roden M
    Diabetes Care; 2018 Jun; 41(6):1235-1243. PubMed ID: 29602794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.